| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |